In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jinghui SunDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0001-5651-9862 Lingling LiuDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Rhyston BroadhurstDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0009-0001-8510-3759 David WangHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Anand MehtaDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Denis C GuttridgeHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Leonardo M R FerreiraDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Haizhen WangDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0003-3477-8673 Xueliang GaoDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0003-4834-0437 Funding
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7MNovel functions of CDK6 in T-cell leukemia progressionR37CA251165 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Haizhen Wang · 2021 to 2026
$2.0MExploring the Novel Functions of Cyclin Ds in T Cells and Tumor ProgressionR01CA298320 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MICHAEL I. NISHIMURA, Haizhen Wang · 2026 to 2026
$643kAmerican Cancer Society IRG-19-137-20Medical University of South Carolina P30 CA138313NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA298320NCI NIH HHS R37 CA251165NCI NIH HHS R37CA251165 & R01CA298320Swim Across America 23-1579
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
combination treatmentmetastasisMSLNpancreatic cancerSERPINB5
Identifiers
PMID42882936
PMCPMC13664176
What OpenQuestion holds
Textmetadata
Read underepoch 390